Medicaid block grants won't work, Scarborough says

Many cash-starved states are pushing for a Medicaid block grant so they can change and reduce provider payments. But this option will be a political disaster, according to Joe Scarborough, co-host of “Morning Joe,” a daily news show on MSNBC.

“Block grants will scare people,” warned Scarborough during a general session address at the ALFA 2011 Conference & Expo in Orlando on Wednesday. He added that physicians and other providers need to participate in efforts to change the healthcare system.

He also predicted that civility would become more common in upcoming elections, despite recent upturns in negative campaign advertising.

“America is ready for civility,” he said. He blamed media outlets — particularly cable television programs — for airing content that reinforces partisan views while demonizing opponents. “The current Congress also needs to become more civil,” Scarborough added.

Scarborough is a former Republican congressman from Florida. His Morning Joe co-host is Mika Brzezinski, the daughter of a former high-ranking Democratic administration official.  The ALFA meeting continues through Thursday.

close

Next Article in News

More in News

Government initiatives aim to decrease number of disabled people in nursing homes

Government initiatives aim to decrease number of disabled ...

The federal government is ramping up efforts to reduce the number of disabled people in nursing homes through interagency initiatives. While many disabled people have already been moved out of ...

Nursing home optometrist faces False Claims suit alleging excessive, unreasonable eye exams ...

An optometrist in Kentucky defrauded Medicare and Medicaid by filing claims for nursing home care that was unnecessary or not provided, alleges a False Claims Act lawsuit recently brought by the federal government.

Fecal transplants to treat C. diff now need FDA approval

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.